Bavarian Nordic CEO Hopes Chordoma Vaccine Can Be Launched By Mid-2020
Danish vaccine specialist's BN-Brachyury has been granted orphan drug designation by the FDA for treating chordoma.
You may also be interested in...
Danish group believes its smallpox vaccine will get approved, generate a transferable priority review voucher, and replace the current US-licensed replicating smallpox vaccine ACAM2000.
Created when BetterLife bought Altum at end-July, the merged entity will now focus on advancing the acquired group’s lead asset, an inhaled form of its patented interferon a2b product, as an early treatment for COVID-19.
Roche’s etrolizumab missed primary endpoints in its Phase III study program evaluating it as maintenance therapy in moderately to severely active ulcerative colitis, a new therapeutic area for the firm.